Published in Neurourol Urodyn on November 01, 2010
Mesh complications in female pelvic floor reconstructive surgery and their management: A systematic review. Indian J Urol (2012) 1.35
Management of recurrent stress urinary incontinence and urinary retention following midurethral sling insertion in women. Ann R Coll Surg Engl (2012) 0.83
Comparison of TOA and TOT for Treating Female Stress Urinary Incontinence: Short-Term Outcomes. Korean J Urol (2010) 0.81
Readjustable sling procedure for the treatment of female stress urinary incontinence with intrinsic sphincter deficiency: preliminary report. Korean J Urol (2010) 0.78
Assessing the Readjustable Sling Procedure (Remeex System) for Female Stress Urinary Incontinence With Detrusor Underactivity. Int Neurourol J (2017) 0.75
Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev (2011) 3.63
Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma. Clin Cancer Res (2010) 2.23
Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains. J Clin Microbiol (2010) 2.19
Molecular lymph node staging in bladder urothelial carcinoma: impact on survival. Eur Urol (2008) 2.04
Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol (2009) 2.03
Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys (2007) 2.02
Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. Eur Urol (2010) 1.99
Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. J Exp Med (2007) 1.93
Inaccuracy of single-target sequencing for discriminating species of the Mycobacterium abscessus group. J Clin Microbiol (2009) 1.91
Laparoscopic kidney transplantation. Eur Urol (2009) 1.68
Protein expression patterns of ezrin are predictors of progression in T1G3 bladder tumours treated with nonmaintenance bacillus Calmette-Guérin. Eur Urol (2008) 1.65
Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys (2008) 1.63
DNA microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers. J Urol (2009) 1.59
Evaluation of the methylation status of tumour suppressor genes for predicting bacillus Calmette-Guérin response in patients with T1G3 high-risk bladder tumours. Eur Urol (2011) 1.55
Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Guérin therapy. Eur Urol (2007) 1.55
Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors. Urology (2009) 1.47
Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma. Can J Urol (2011) 1.44
Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma. Eur Urol (2006) 1.14
Evaluation of tuberculosis transmission in Tehran: using RFLP and spoligotyping methods. J Infect (2004) 1.10
Population dynamics of tuberculous Bacilli in Cameroon as assessed by spoligotyping. J Clin Microbiol (2012) 1.09
Conservative surgical therapy for leydig cell tumor. J Urol (2007) 1.02
A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis (2003) 0.99
Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD. Am J Kidney Dis (2006) 0.99
Primary congenital bladder diverticula in children. Urology (2007) 0.98
Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma. Am J Ophthalmol (2013) 0.98
Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. J Urol (2004) 0.98
Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence. Ann Surg Oncol (2010) 0.97
Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor. J Urol (2005) 0.92
Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population. World J Urol (2014) 0.92
The case for conservative management in the treatment of patients with non-muscle-invasive micropapillary bladder carcinoma without carcinoma in situ. Can J Urol (2010) 0.90
Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer. Cancer Genet Cytogenet (2007) 0.89
Clinical benefits, costs, and cost-effectiveness of neonatal intensive care in Mexico. PLoS Med (2010) 0.89
Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state. Am J Kidney Dis (2004) 0.89
Prevalence of antiretroviral drug resistance among treatment-naive and treated HIV-infected patients in Venezuela. Mem Inst Oswaldo Cruz (2009) 0.88
Utility of urothelial mRNA markers in blood for staging and monitoring bladder cancer. Urology (2011) 0.86
Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol (2008) 0.86
Hemangioma of the prostatic urethra: holmium laser treatment. Urol Int (2008) 0.86
Prepubertal testicular tumours and efficacy of testicular preserving surgery. BJU Int (2010) 0.85
Neoadjuvant temsirolimus effectiveness in downstaging advanced non-clear cell renal cell carcinoma. Eur Urol (2010) 0.84
Long-term improvement of deceased donor renal allograft survival since 1996: a single transplant center study. Transplantation (2010) 0.84
Mannose-binding lectin gene polymorphisms are associated with gestational diabetes mellitus. J Clin Endocrinol Metab (2004) 0.84
Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010. BJU Int (2012) 0.84
Primary obstructive megaureter: initial experience with endoscopic dilatation. J Endourol (2007) 0.83
Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity. Radiat Oncol (2014) 0.83
External beam radiotherapy plus high-dose-rate brachytherapy for treatment of locally advanced prostate cancer: the initial experience of the Catalan Institute of Oncology. Brachytherapy (2009) 0.83
[Practical guideline for the management of adverse events associated with BCG installations]. Arch Esp Urol (2008) 0.83
Detrusor quantitative morphometry in obstructed males and controls. J Urol (2006) 0.83
Fluorescence in situ hybridization analysis of matched primary tumour and lymph-node metastasis of D1 (pT2-3pN1M0) prostate cancer. BJU Int (2004) 0.82
Efficiency of endoscopic treatment for vesico-ureteric reflux in adults. BJU Int (2008) 0.82
[Bilateral laparoscopic nephrectomy for renal cancer]. Arch Esp Urol (2004) 0.82
Diagnosis, risk factors, and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients. Eur Urol (2007) 0.81
Embolization of a bleeding aneurysm in a patient with spontaneous perirenal haematoma due to Polyarteritis nodosa. Arch Esp Urol (2005) 0.81
Laparoscopic management of spontaneous retroperitoneal hemorrhage. Urol Int (2011) 0.81
Sorafenib: tolerance in patients on chronic hemodialysis: a single-center experience. Oncology (2008) 0.80
Laparoscopic live donor nephrectomy with the use of 3-mm instruments and laparoscope: initial experience at a tertiary center. Eur Urol (2011) 0.80
The 3-day bladder diary is a feasible, reliable and valid tool to evaluate the lower urinary tract symptoms in women. Neurourol Urodyn (2013) 0.80
[Early ultrasound detection of renal tumors in patients with end stage renal disease in dialysis]. Arch Esp Urol (2007) 0.80
[The presence of a prolene mesh in the vagina]. Arch Esp Urol (2006) 0.80
Genetic diversity and population structure of Mycobacterium marinum: new insights into host and environmental specificities. J Clin Microbiol (2012) 0.80
Ursolic acid inhibits neointima formation in the rat carotid artery injury model. Atherosclerosis (2006) 0.80
[Lithiasis in complete ureteral duplication and prostate cancer: combined surgery treatment]. Arch Ital Urol Androl (2003) 0.80
Line probe and automated real-time PCR TB assays warrant adherence to strict quality assurance measures. Int J Tuberc Lung Dis (2012) 0.80
Management of urethral recurrence in patients with Studer ileal neobladder. Eur Urol (2003) 0.79
A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family. Breast Cancer Res Treat (2009) 0.79
Disseminated retroperitoneal choriocarcinoma with open fistula to intestine. "Restitutio ad integrum" with chemotherapy alone. Clin Transl Oncol (2006) 0.79
Tissue engineered testicular prostheses with prolonged testosterone release. World J Urol (2008) 0.78
Clinical predictive factors of poor outcome in patients with stage pT0 disease at radical cystectomy. J Urol (2011) 0.78
Is bladder cycling useful in the urodynamic evaluation previous to renal transplantation? Urol Int (2005) 0.78
Relative survival of patients with uveal melanoma managed in a single center. Melanoma Res (2012) 0.78
The road to real zero ischemia for partial nephrectomy. J Endourol (2013) 0.78
[Vesico-ureteral reflux, endoscopic management]. Arch Argent Pediatr (2013) 0.77
Cystatin C and cardiac hypertrophy in primary hypertension. Blood Press (2010) 0.77
Incidence of contralateral germ cell testicular tumors in South Europe: report of the experience at 2 Spanish university hospitals and review of the literature. J Urol (2004) 0.76
Palliative care intervention in the intensive care unit: comparing outcomes among seriously ill Asian patients and those of other ethnicities. J Palliat Care (2014) 0.76
Role of oxidative stress in cardiovascular effects of anemia treatment with erythropoietin in predialysis patients with chronic kidney disease. Clin Nephrol (2012) 0.76
[Percutaneous treatment of a primary renal aspergilloma in a patient with AIDS]. Arch Ital Urol Androl (2003) 0.76
Are physicians' recommendations on limiting life support really burdensome? Am J Respir Crit Care Med (2010) 0.75
Re: Skeletal fracture associated with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer. J Urol (2002) 0.75
Association between 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene with stroke or encephalopathy after cardiac surgery. Intensive Care Med (2006) 0.75
Invasive bladder cancer in the eighties: transurethral resection or cystectomy? Int Braz J Urol (2011) 0.75
Simplified technique for parastomal hernia repair after radical cystectomy and ileal conduit creation. Urology (2011) 0.75
Mucosal fold as a mechanical cause of obstruction in orthotopic ileal neobladder. Arch Ital Urol Androl (2004) 0.75
[Overview of the results of the treatment of transitional cell carcinoma by ureteroscopy]. Arch Esp Urol (2004) 0.75
[Paraurethral cyst of the Littre's gland: an exceptional case]. Arch Esp Urol (2006) 0.75
[Renal artery aneurysm]. Arch Esp Urol (2007) 0.75
[High flow priapism. Case report]. Arch Esp Urol (2006) 0.75
[Thyroid metastasis of a renal carcinoma. Case report]. Arch Esp Urol (2006) 0.75
[Allogeneic transplantation of peripheral blood hematopoietic stem-cells with low intensity conditioning for the treatment of a metastatic clear cell carcinoma. Preliminary results after two years of follow-up]. Arch Esp Urol (2006) 0.75
Acute Renal Failure Secondary to Rhabdomyolysis as a Complication of Major Urological Surgery: The Experience of a High-Volume Urological Center. Med Princ Pract (2016) 0.75
Late cerebral relapse of a Mycobacterium avium complex disseminated infection in an HIV-infected patient after cessation of antiretroviral therapy. AIDS (2003) 0.75
Mini-laparoscopic live donor nephrectomy with the use of 3-mm instruments and laparoscope. World J Urol (2014) 0.75
Kidney transplants in patients with bladder augmentation: correlation and evolution. Int Urol Nephrol (2007) 0.75
[Mixed transitional cell and small cell carcinoma of the bladder with metastases with neuroendocrine histology only. Case report and bibliography review]. Arch Esp Urol (2007) 0.75
Early experience of a living donor kidney transplant program. Eur Urol (2006) 0.75
[Protocol for ureteroscopy in the diagnosis and treatment of the upper urinary tract transitional cell carcinoma]. Arch Esp Urol (2004) 0.75
Alloplastic bladder substitution: are we making progress? Int Urol Nephrol (2012) 0.75